Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-04 | New | $11,499,999 | $11,499,999 | Equity Only | 06b | SEC link |
| 2024-08-15 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
| 2023-03-03 | New | $3,090,000 | $3,090,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mel Sorensen John | Director, Executive |
| Martin Matthew | Executive |
| Gilbert S. Omenn | Director |
| John Mel Sorensen | Director, Executive |
| Shaomeng Wang | Director |
| Brian Wood | Executive |